1. Home
  2. BIOA vs OVID Comparison

BIOA vs OVID Comparison

Compare BIOA & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$10.46

Market Cap

481.0M

Sector

Health Care

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$2.84

Market Cap

522.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOA
OVID
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.0M
522.6M
IPO Year
2024
2017

Fundamental Metrics

Financial Performance
Metric
BIOA
OVID
Price
$10.46
$2.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$51.50
$4.60
AVG Volume (30 Days)
1.3M
1.5M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
66.21
3.90
EPS
N/A
N/A
Revenue
$8,995,000.00
$7,252,000.00
Revenue This Year
$720.93
N/A
Revenue Next Year
N/A
$19.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1181.27
52 Week Low
$4.39
$0.89
52 Week High
$25.96
$3.11

Technical Indicators

Market Signals
Indicator
BIOA
OVID
Relative Strength Index (RSI) 30.99 64.33
Support Level $7.95 $2.22
Resistance Level $13.17 $3.05
Average True Range (ATR) 1.04 0.15
MACD -0.25 0.05
Stochastic Oscillator 10.27 88.89

Price Performance

Historical Comparison
BIOA
OVID

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: